Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety of two doses of Z-360 with Gemcitabine administration for subjects
with unresectable advanced pancreatic cancer in order to determine the optimal dosage for
PhaseII study